How low can teladoc go?

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 42.00, with a high estimate of 65.00 and a low estimate of 30.00. The median estimate represents a +20.59% increase from the last price of 34.83.

Why is Teladoc down so much?

Teladoc stock fell in after-hours trading Tuesday after the telehealth giant posted fourth-quarter earnings, despite results exceeding Wall Street's expectations on profit and revenue.

Will Teladoc ever be profitable?

The telehealth giant isn't yet profitable and reported a loss of $84.3 million in the third quarter of 2021, deeper than its year-prior loss of $36 million. Shares of Teladoc stock fell 6.2% on Monday as of 10:47 a.m. in New York.

Is Teladoc going under?

Shares of struggling telehealth company Teladoc Health (TDOC -3.32%) collapsed after it recently released earnings for the first quarter of 2022.

Will Teladoc ever recover?

The company does have a promising future in terms of the growing need and adoption of telemedicine. Teladoc is also aiming to reach $2.6 Billion in annual revenue next year, and the company is striving to reach $4 billion in revenue by 2024.

How Much Lower Can Teladoc Stock Go? | TDOC Stock

Is teladoc undervalued?

The revenue per member was reported $2.32 in 2021, up from $1.12 in 2020. I believe Teladoc's stock price is undervalued based on relative valuation indicators. The stock's price-to-sales ratio hit below 4 in mid-March (lowest since 2016) and is trading at 5.33, while the price-to-book ratio is at 0.69.

Is teladoc overvalued?

Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.

Is Teladoc a good company?

The employee experience below at Teladoc Health (formerly Livongo), compared to a typical company. 84% of employees at Teladoc Health (formerly Livongo) say it is a great place to work compared to 57% of employees at a typical U.S.-based company. Source: Great Place to Work® 2021 Global Employee Engagement Study.

Is Tdoc buy or sell?

Today TDOC ranks #676 as buy candidate.

Who are Teladoc competitors?

Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.

What was Teladoc IPO price?

Telehealth platform company Teladoc, on Tuesday, announced that its initial public offering would be priced at $19 per share, raising $157 million, according to a Renaissance Capital post to NASDAQ.com.

How many people work for teladoc?

Teladoc Health total number of employees in 2021 was 5,100, a 15.91% increase from 2020. Teladoc Health total number of employees in 2020 was 4,400, a 83.33% increase from 2019. Teladoc Health total number of employees in 2019 was 2,400, a 20% increase from 2018.

What is teladoc PE ratio?

s P/E Ratio (Fwd): Dec 2022 Dec 2025 Dec 2028 Dec 2031 -20.0x 20.0x 60.0x. Teladoc Health's p/e ratio (fwd) is -25.7x.

Is Zoom a buy?

Strong growth continues

Zoom's recent earnings release was for Q3 of the fiscal year 2023, ending April 30, 2022. Revenue for the quarter was $1.1 billion, up 12% year over year. While that growth may not appear impressive at first glance, it's important to remember that it was on top of 191% growth in Q3 of 2022.

Is Nvidia a buy?

Nvidia is a top pick for growth investors

The segment produced $3.75 billion in revenue, which was an 83% increase over the prior-year period and accounted for 45% of the company's top line.

Is PayPal a buy?

PayPal Stock Fundamental Analysis: A Strong Track Record

For 2020, the firm's earnings grew 31% to $3.88 a share. In 2021, the company's EPS grew 18% to $4.60. But analysts expect the company's EPS to fall 16% in 2022 before rising 24% in 2023.

Is Teladoc owned by Aetna?

Teladoc and Teladoc physicians are independent contractors and are not agents of Aetna.

Does Teladoc have its own doctors?

All the doctors in Teladoc's national network are U.S. board-certified family practitioners, primary care physicians, pediatricians and internists who use Electronic Health Records to diagnose, treat and write prescriptions when necessary. When accessing Teladoc, you'll be connected to a doctor in your state.

Are Teladoc shares a buy?

There are currently 18 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Teladoc Health stock.